Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359920070260060716
Korean Journal of Nephrology
2007 Volume.26 No. 6 p.716 ~ p.724
Association of Transforming Growth Factor-beta 1 Gene Polymorphisms with Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients
Cho Seong

Kim Chan-Duck
Ryu Hye-Myung
Park Sun-Hee
Kim Yong-Lim
Abstract
Purpose: Atherosclerotic vascular disease (AVD) is a leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD) on peritoneal dialysis (PD). Transforming growth factorbeta 1 (TGF-¥â1) is a multifunctional cytokine that inhibits the atheromatous process. The author studied polymorphisms of the TGF-¥â1 gene (-509C>T and 869T>C) as genetic susceptibility factors for AVD in PD patients.

Methods: Genotyping was carried out using the LightCycler 480 with melting curve analysis function. Prevalent vascular disease was defined by the presence of ischemic heart disease (IHD), peripheral vascular disease (PVD), cerebrovascular disease (CVD), or congestive heart failure (CHF). The presence of AVD was derived by the presence of any vascular disease (i.e., any degree of IHD/PVD/CVD).

Results: In total, 109 PD patients were recruited (38.7% male, and 28.7% diabetic). The mean age was 49.1¡¾14.1 years, and mean dialysis duration was 61.3¡¾34.1 months. The most frequent genotype at -509C>T was CT (49.5%) and at 869T>C was TC (47.7%). No significant differences were observed in the genotype distributions of the investigated TGF-¥â1 (CC:CT:TT, 18.5%:55.6%:25.9% vs 26.8%:47.6%:25.6%, ¥ö2=0.246, p=0.884; TT:TC:CC, 18.5%:55.6%:25.9% vs 28.0%:45.1%:26.8%, ¥ö2=1.188, p=0.552) between AVD group and no AVD group.

Conclusion: TGF-¥â1 gene polymorphisms at both -509C>T and +869T>C were not associated with an increased risk for prevalent vascular diseases. Further studies are required to evaluate the role of TGF-¥â1 as a candidate gene.
KEYWORD
TGF-beta 1, Peritoneal dialysis, Genetic polymorphisms, Atherosclerosis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø